XML 15 R6.htm IDEA: XBRL DOCUMENT v3.25.2
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
$ in Thousands
 3 Months Ended 6 Months Ended 7 Months Ended
Jun. 30, 2025
Jun. 30, 2024
Jun. 30, 2025
Jun. 30, 2024
Dec. 31, 2023
Dec. 31, 2024
Cash flows from operating activities:            
Net loss before income tax $ (82,047) $ (17,217) $ (455,633) $ (58,849)    
Adjustments to reconcile net loss to net cash used in operating activities:            
Depreciation, amortization, and accretion     43,356 40,079    
Goodwill impairment and other charges 0 0 415,897 0    
Non-cash income     (1,025) (1,376)    
Deferred taxes     (1,227) (6,391)    
Change in fair value of Earnout Shares liability and Warrant liability     (75,580) (1,671)    
Change in Tax Receivable Agreement liability 0 0 (21,317) 0    
Share-based compensation expense     24,103 14,800    
Changes in operating assets and liabilities:            
Accounts receivable, net     0 (185)    
Interest receivable     2,896 1,611    
Prepaid expenses and other current assets     (1,606) (825)    
Other long-term assets     (15) (420)    
Accounts payable     (2,047) 1,367    
Accrued liabilities     4,302 935    
Due to related parties     22,922 88    
Net cash used in operating activities     (44,974) (10,837)    
Cash flows from investing activities:            
Purchases of available-for-sale securities     (130,602) (121,656)    
Maturities of available-for-sale securities     43,350 20,750    
Maturities of short-term investments     100,000 0    
Capitalized software     (834) (412)    
Purchase of property, plant and equipment     (12,023) (17,273)    
Net cash used in investing activities     (109) (118,591)    
Cash flows from financing activities:            
Issuance of Class A Common Stock, including exercise of Warrants     0 61    
Payments on finance lease obligations     (99) 0    
Net cash (used in) provided by financing activities     (99) 61    
Net decrease in cash, cash equivalents, and restricted cash     (45,182) (129,367)    
Cash, cash equivalents, and restricted cash, beginning of period     331,676 536,927    
Cash, cash equivalents, and restricted cash, end of period 286,494 407,560 286,494 407,560 $ 536,927  
Supplemental non-cash investing and financing activities:            
Change in accruals for capital expenditures     (1,612) 120    
Operating lease right-of use asset acquired     1,591   0  
Reconciliation of cash, cash equivalents, and restricted cash to the consolidated balance sheet:            
Cash and cash equivalents 284,024 405,145 284,024 405,145   $ 329,230
Restricted cash 2,470 2,415 2,470 2,415   2,446
Total cash, cash equivalents, and restricted cash $ 286,494 $ 407,560 $ 286,494 $ 407,560 $ 536,927 $ 331,676